10 / July / 2026 Cancer treatments advance, but clinical trials lack diversity Most drugs are tested on populations from wealthy countries—expanding participation to other regions could make therapies more effective for different patient profiles By Gabriela Monteiro
06 / July / 2026 In vivo CAR-T: therapy produces anti-cancer cells in the body Experimental approach uses viral vectors and nanoparticles to reprogram immune cells directly within the body, eliminating the need to manufacture cells in a lab By Rodrigo de Oliveira Andrade
16 / June / 2026 Electroacupuncture may help treat chemotherapy-induced pain Phase 3 study presented at the ASCO Annual Meeting evaluates the technique as a nonpharmacological alternative for peripheral neuropathy in cancer patients By Samuel Antenor
10 / June / 2026 Cancer clinical trials grow more slowly than expected in Brazil, study finds A 20-year analysis shows that the country has made progress but still faces regulatory and cultural barriers, as well as reliance on the pharmaceutical industry. By Gabriela Monteiro
03 / June / 2026 Daraxonrasib: the story of a drug that took 44 years to develop A New York Times report chronicles four decades of research culminating in the development of daraxonrasib, a drug that doubled the overall survival of patients with metastatic pancreatic cancer By Diogo Rodriguez
02 / June / 2026 Pancreatic cancer: Oral drug almost doubles survival in clinical trial Data presented at ASCO 2026 showed that daraxonrasib reduced the risk of death by 60% in patients with metastatic pancreatic cancer By Daniel Dieb
29 / May / 2026 Leukemia caused by a virus transmitted through breastfeeding could be prevented with maternal screening With incidence rates up to 32 times higher among Caribbean immigrants and cases often mistaken for other lymphomas, ATLL is an underrecognized disease for which Japan now has prevention measures By Gilberto Stam
16 / January / 2026 Ignored risk: NEJM issues warning about smokeless tobacco Smokeless tobacco accounts for a significant share of oral cancer cases worldwide, warns influential medical journal By Bruno de Pierro
28 / July / 2025 “Scientists need to speak social network language” Settled in the USA, a Brazilian biomedical engineer turns his research routine into content for thousands of followers on social networks By Letícia Naísa
23 / May / 2025 The frontiers of cancer treatment New inhibitors revolutionize cancer treatment, but tumor cell resistance demands a different approach By Julia Rezende da Silva
